Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and Carcinoma, Squamous Cell

1,2-distearoylphosphatidylethanolamine has been researched along with Carcinoma, Squamous Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D; Chen, H; Chen, M; Chen, S; Dong, Y; Hua, L; Li, M; Song, X; Zhang, C; Zhang, Y; Zheng, H; Zhu, M1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Carcinoma, Squamous Cell

ArticleYear
Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells.
    Nanomedicine (London, England), 2017, Volume: 12, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Head and Neck Neoplasms; Humans; Male; Methotrexate; Mice, Inbred BALB C; Mice, Nude; Micelles; Neoplastic Stem Cells; Phosphatidylethanolamines; Polyethylene Glycols; Pyrans; Squamous Cell Carcinoma of Head and Neck

2017